RhumbLine Advisers
KIDS icon

RhumbLine Advisers’s OrthoPediatrics KIDS Stock Holding History

RhumbLine Advisers’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$329K Sell
20,710
-1,463
-7% -$25.6K ﹤0.01% 2874
2025
Q4 		$394K Sell
22,173
-3,260
-13% -$57.1K ﹤0.01% 2809
2025
Q3 		$471K Sell
25,433
-407
-2% -$8.38K ﹤0.01% 2735
2025
Q2 		$555K Buy
25,840
+240
+0.9% +$5.19K ﹤0.01% 2623
2025
Q1 		$631K Sell
25,600
-811
-3% -$20K ﹤0.01% 2419
2024
Q4 		$612K Buy
26,411
+1,042
+4% +$26.1K ﹤0.01% 2536
2024
Q3 		$688K Sell
25,369
-1,244
-5% -$37.7K ﹤0.01% 2495
2024
Q2 		$765K Buy
26,613
+4,245
+19% +$130K ﹤0.01% 2391
2024
Q1 		$652K Buy
22,368
+513
+2% +$14.3K ﹤0.01% 2500
2023
Q4 		$710K Buy
21,855
+60
+0.3% +$1.74K ﹤0.01% 2464
2023
Q3 		$697K Buy
21,795
+924
+4% +$35.6K ﹤0.01% 2409
2023
Q2 		$915K Buy
20,871
+501
+2% +$23.1K ﹤0.01% 2339
2023
Q1 		$902K Buy
20,370
+1,182
+6% +$52.2K ﹤0.01% 2169
2022
Q4 		$762K Buy
19,188
+391
+2% +$16.3K ﹤0.01% 2271
2022
Q3 		$867K Buy
18,797
+2,316
+14% +$114K ﹤0.01% 2220
2022
Q2 		$711K Buy
16,481
+2,760
+20% +$126K ﹤0.01% 2315
2022
Q1 		$741K Buy
13,721
+865
+7% +$44.2K ﹤0.01% 2255
2021
Q4 		$770K Sell
12,856
-251
-2% -$15.6K ﹤0.01% 2323
2021
Q3 		$859K Buy
13,107
+569
+5% +$37K ﹤0.01% 2296
2021
Q2 		$792K Sell
12,538
-540
-4% -$31K ﹤0.01% 2345
2021
Q1 		$638K Sell
13,078
-1,045
-7% -$50.2K ﹤0.01% 2382
2020
Q4 		$583K Buy
14,123
+1,197
+9% +$54.9K ﹤0.01% 2381
2020
Q3 		$594K Sell
12,926
-1,850
-13% -$85.8K ﹤0.01% 2207
2020
Q2 		$647K Buy
14,776
+3,345
+29% +$150K ﹤0.01% 2228
2020
Q1 		$453K Buy
11,431
+661
+6% +$29.6K ﹤0.01% 2205
2019
Q4 		$506K Buy
10,770
+111
+1% +$4.3K ﹤0.01% 2356
2019
Q3 		$376K Buy
10,659
+5
+0% +$173 ﹤0.01% 2452
2019
Q2 		$416K Buy
10,654
+1,304
+14% +$52.6K ﹤0.01% 2437
2019
Q1 		$414K Buy
9,350
+580
+7% +$22.1K ﹤0.01% 2405
2018
Q4 		$306K Buy
8,770
+3,129
+55% +$99.1K ﹤0.01% 2535
2018
Q3 		$207K Buy
+5,641
New +$173K ﹤0.01% 2712

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RhumbLine Advisers's KIDS Position: Q1 2026 in Review

RhumbLine Advisers reduced its OrthoPediatrics (KIDS) stake by 6.6% in Q1 2026, selling an estimated $25.6K and leaving 20,710 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.

RhumbLine Advisers first reported a position in KIDS in Q3 2018 and has held it in 31 quarters since. The position peaked at $915K in Q2 2023. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • RhumbLine Advisers held 20,710 shares of OrthoPediatrics worth $329K as of Q1 2026.
  • RhumbLine Advisers sold 1,463 OrthoPediatrics shares in Q1 2026, an estimated $25.6K.
  • OrthoPediatrics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2874 holding.
  • RhumbLine Advisers first reported a position in OrthoPediatrics in Q3 2018 and has held it in 31 quarters since.
  • RhumbLine Advisers's OrthoPediatrics position peaked at $915K in Q2 2023.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.